Bristol-Myers Squibb Co (BMY) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −1,15%	1 087,89	−12,68	−1,15%	—	1 100,57	1 098,94	1 103,80	1 084,24	—	—
SIXC Communications SIXC Communications	SIXC −0,33%	603,16	−1,99	−0,33%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +1,95%	1 218,52	+23,33	+1,95%	—	1 195,19	1 204,71	1 221,69	1 204,71	—	—
SIXI Industrials SIXI Industrials	SIXI −1,35%	1 716,37	−23,54	−1,35%	—	1 739,91	1 734,50	1 734,50	1 710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,44%	641,34	+2,78	+0,44%	—	638,56	640,21	645,32	639,66	—	—
SIXR Staples SIXR Staples	SIXR +1,26%	842,07	+10,50	+1,26%	—	831,57	840,48	844,16	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,57%	214,58	+1,22	+0,57%	—	213,36	213,36	215,54	212,77	—	—
SIXT Technology SIXT Technology	SIXT −2,30%	3 159,71	−74,47	−2,30%	—	3 234,18	3 171,86	3 195,36	3 145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,22%	937,70	+2,05	+0,22%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,15%	1 451,46	+2,20	+0,15%	—	1 449,26	1 454,77	1 462,65	1 451,23	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,59%	2 368,43	−14,02	−0,59%	—	2 382,45	2 371,19	2 380,45	2 364,46	—	—

Inntekt Q1 2026 • om 2 dager

Se detaljene

BMY:NYSE

Bristol-Myers Squibb Co

57,95 USD

+0,29%

(+0,17) 1 D

28. apr., 13:04:10 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for BMY …

Åpne

58,58 USD

Høy

58,73 USD

Lav

57,94 USD

Markedsverdi

118,32 mrd.

Snittvolum

11,98 mill.

Volum

2,36 mill.

Utbytte

4,35 %

Kvartalsvis utbytte

0,63 USD

Første dato etter utbytte

2. jan. 2026

P/E-forhold

16,75

52 u høy

62,89 USD

52 u lav

42,52 USD

EPS

3,46 USD

Beta

0,27

Utestående aksjer

2,04 mrd.

Antall ansatte

32k

Relaterte aksjer

Nyhetssaker

Fra kilder på nettet

GuruFocus

for 5 timer siden

Is BMY Undervalued? DCF Says Worth $76

MarketBeat

for 5 timer siden

Bristol Myers Squibb Company $BMY Stock Position Reduced by R Squared Ltd

AOL.com

for 16 timer siden

3 Healthcare Stocks That Pay You While You Wait for the Growth

IndexBox

for 20 timer siden

Bristol Myers Squibb Stock Gains 20% Amid 2026 Revenue Outlook

Profil

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia

Om Bristol-Myers Squibb Co

Administrerende direktørChris Boerner

Ansatte32,5k

Grunnlagt1887

HovedkontorNew York, New York, USA

Sektor-

Nettstedbms.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	11,20 mrd.	12,27 mrd.	12,22 mrd.	12,50 mrd.
Varekostnad	3,02 mrd.	3,36 mrd.	3,31 mrd.	3,51 mrd.
Direkte driftskostnader	3,02 mrd.	3,36 mrd.	3,31 mrd.	3,51 mrd.
Utgifter til forskning og utvikling	2,24 mrd.	2,26 mrd.	2,43 mrd.	2,56 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	1,58 mrd.	1,69 mrd.	1,79 mrd.	2,09 mrd.
Driftskostnader	4,65 mrd.	4,78 mrd.	5,05 mrd.	5,47 mrd.
Totale driftskostnader	7,66 mrd.	8,14 mrd.	8,36 mrd.	8,98 mrd.
Driftsinntekter	3,54 mrd.	4,13 mrd.	3,86 mrd.	3,52 mrd.
Andre ikke-operasjonelle inntekter	494,00 mill.	399,00 mill.	529,00 mill.	544,00 mill.
EBT inkludert uvanlige elementer	2,97 mrd.	1,77 mrd.	3,11 mrd.	1,47 mrd.
EBT uten uvanlige elementer	3,70 mrd.	4,22 mrd.	4,07 mrd.	3,86 mrd.
Kostnad for inntektsskatt	509,00 mill.	460,00 mill.	919,00 mill.	384,00 mill.
Faktisk avgiftssats	17,13 %	25,96 %	29,51 %	26,12 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	2,46 mrd.	1,31 mrd.	2,20 mrd.	1,09 mrd.
Netto fortjenestemargin	21,93 %	10,68 %	18,01 %	8,69 %
Resultat per aksje	1,80	1,46	1,63	1,26
Rente- og investeringsinntekter	138,00 mill.	139,00 mill.	161,00 mill.	148,00 mill.
Rentekostnader	−493,00 mill.	−485,00 mill.	−482,00 mill.	−432,00 mill.
Netto rentekostnader	−355,00 mill.	−346,00 mill.	−321,00 mill.	−284,00 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	4,55 mrd.	5,12 mrd.	4,91 mrd.	4,54 mrd.
Gevinst eller tap ved salg av eiendeler	−20,00 mill.	−7,00 mill.	−9,00 mill.	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning